Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 81.3% | 118.0% | 41.1% | 73.3% | 45.9% | 94.8% | 98.7% | 74.5% | 90.4% | 89.1% | 96.3% | 69.5% | 121.5% | 112.6% | 73.5% | 71.0% | 92.8% | 85.4% | 58.0% | 91.5% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 85.6%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for IDEXX Laboratories, Inc. have been 81.7% over the past three years, and 86.1% over the past five years.
As of today, IDEXX Laboratories, Inc.'s FCF to Net Income is 85.6%, which is lower than industry median of 86.3%. It indicates that IDEXX Laboratories, Inc.'s FCF to Net Income is Bad.